Literature DB >> 17576746

SUT-1 enables tau-induced neurotoxicity in C. elegans.

Brian C Kraemer1, Gerard D Schellenberg.   

Abstract

We previously reported a transgenic Caenorhabditis elegans model for tauopathies in which expression of human tau in neurons caused insoluble phosphorylated tau accumulation, neurodegeneration and uncoordinated movement (Unc). To identify genes participating in tau neurotoxicity, we conducted a forward genetic screen for mutations that ameliorate tau-induced uncoordination. The recessive mutation sut-1(bk79) partially suppresses the Unc phenotype, tau aggregation and neurodegenerative changes caused by tau. We identified the sut-1 gene and found it encodes a novel protein. We conducted a yeast two hybrid screen to identify SUT-1 binding partners and found UNC-34, the C. elegans homolog of the cytoskeletal regulatory protein Enabled (ENA). In vitro protein binding assays and genetic studies validated the interaction between SUT-1 and UNC-34. The SUT-1/UNC-34 protein-protein interaction plays a role in both the normal function of UNC-34 and in the tau-induced phenotype. Thus, we have found a conserved molecular pathway participating in tau neurotoxicity in C. elegans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576746     DOI: 10.1093/hmg/ddm143

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  34 in total

Review 1.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

2.  MSUT2 is a determinant of susceptibility to tau neurotoxicity.

Authors:  Chris R Guthrie; Lynne Greenup; James B Leverenz; Brian C Kraemer
Journal:  Hum Mol Genet       Date:  2011-02-25       Impact factor: 6.150

Review 3.  Watching worms whither: modeling neurodegeneration in C. elegans.

Authors:  Benjamin Wolozin; Christopher Gabel; Andrew Ferree; Maria Guillily; Atsushi Ebata
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

4.  Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity.

Authors:  Allyson V McCormick; Jeanna M Wheeler; Chris R Guthrie; Nicole F Liachko; Brian C Kraemer
Journal:  Biol Psychiatry       Date:  2012-11-07       Impact factor: 13.382

5.  Potential neuroprotective strategies against tauopathy.

Authors:  Jeanna M Wheeler; Chris R Guthrie; Brian C Kraemer
Journal:  Biochem Soc Trans       Date:  2012-08       Impact factor: 5.407

6.  Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy.

Authors:  Nicole F Liachko; Chris R Guthrie; Brian C Kraemer
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

Review 7.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

Review 8.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

9.  CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration.

Authors:  Nicole F Liachko; Pamela J McMillan; Chris R Guthrie; Thomas D Bird; James B Leverenz; Brian C Kraemer
Journal:  Ann Neurol       Date:  2013-07-08       Impact factor: 10.422

10.  What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?

Authors:  Dawn Teschendorf; Christopher D Link
Journal:  Mol Neurodegener       Date:  2009-09-28       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.